REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 78 filers reported holding REVOLUTION MEDICINES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,828,900 | +5.2% | 933,125 | +1.7% | 0.01% | 0.0% |
| Q2 2023 | $24,548,288 | +44.3% | 917,693 | +16.8% | 0.01% | +66.7% |
| Q1 2023 | $17,015,164 | +5.7% | 785,557 | +16.3% | 0.00% | 0.0% |
| Q4 2022 | $16,094,507 | +24.2% | 675,672 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $12,955,000 | +4.0% | 656,960 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $12,457,000 | -22.5% | 639,164 | +1.5% | 0.00% | 0.0% |
| Q1 2022 | $16,067,000 | +13.8% | 629,849 | +12.3% | 0.00% | +50.0% |
| Q4 2021 | $14,122,000 | -8.3% | 561,055 | +0.2% | 0.00% | -33.3% |
| Q3 2021 | $15,396,000 | -14.3% | 559,668 | -1.1% | 0.00% | 0.0% |
| Q2 2021 | $17,962,000 | -17.0% | 565,915 | +19.9% | 0.00% | -25.0% |
| Q1 2021 | $21,648,000 | +23.1% | 471,853 | +6.2% | 0.00% | +33.3% |
| Q4 2020 | $17,588,000 | +11.9% | 444,270 | -1.7% | 0.00% | 0.0% |
| Q3 2020 | $15,722,000 | +153.5% | 451,768 | +129.9% | 0.00% | +200.0% |
| Q2 2020 | $6,202,000 | +88.2% | 196,483 | +30.6% | 0.00% | 0.0% |
| Q1 2020 | $3,296,000 | – | 150,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |